We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Otsuka Wins Abilify Patent Dispute, Barring Generics Until 2015
Otsuka Wins Abilify Patent Dispute, Barring Generics Until 2015
November 23, 2010
Japanese drugmaker Otsuka Pharmaceutical has won a major victory against several companies seeking to make generic versions of its blockbuster antipsychotic Abilify after a federal judge upheld a key patent related to the drug’s active ingredient.